Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

It’s not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, including in the U.S.

While there is no visible catalyst for a recession, fading stimulus effects suggest the U.S. economy is likely to slow in ...